HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

benzyloxycarbonyl- leucyl- leucyl- leucylboronate

structure in first source

Also Known As:

Cbz-LLL-B(OH)2; Cbz-Leu-Leu-Leu-B(OH)2; Z-Leu-Leu-Leu-B(OH)2; ZL3B peptide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Boron Compounds: 91
  - benzyloxycarbonyl-leucyl-leucyl-leucylboronate: 1
Organic Chemicals: 133
- Boron Compounds: 91
  - benzyloxycarbonyl-leucyl-leucyl-leucylboronate: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - benzyloxycarbonyl-leucyl-leucyl-leucylboronate: 1

Experts

1.	Brandenburg, Jens: 1 article (10/2007)
2.	El Bissati, Kamal: 1 article (10/2007)
3.	Günzl, Arthur: 1 article (10/2007)
4.	Mamoun, Choukri Ben: 1 article (10/2007)
5.	Reynolds, Jennifer M: 1 article (10/2007)

Related Diseases

1.	Multiple Myeloma 10/23/2007 - "Proteasome inhibitor bortezomib (Velcade: [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl) amino]propyl]amino]butyl] boronic acid), which has been approved for treatment of patients with multiple myeloma, and a second boronate analog Z-Leu-Leu-Leu-B(OH)2 (ZL3B), were tested against four different strains of P. "

Related Drugs and Biologics

1.	Proteasome Inhibitors
2.	Boronic Acids
3.	Bortezomib (Velcade)